Liver-specific ATGL overexpression decreases hepatic steatosis and slightly improves liver insulin sensitivity [26], and hepatic ATGL expression is positively associated with fatty acid β-oxidation [27]. The gene discussed is PNPLA2; the disease is Hepatic steatosis.